Rafa’s Moonshot:
Landing a Cure
for STXBP1

Turning groundbreaking research and harnessing cutting-edge technologies into real hopes in a fight against rare genetic diseases.

Journeying to the Moon and Beyond for Raphael’s Future

“We found something..”

the words echoed around us. Raphael, our little angel, lay sleeping in his stroller, oblivious to the life-altering words being spoken. “We found something in Raphael’s genetic sequencing,” the doctor said.

“It’s a Mutation in the STXBP1 Gene”

Our heads were spinning as we heard devastating terms like epilepsy, global developmental delay, intellectual disability, non-verbal, and more.

“Unfortunately, There is no cure”

the doctor eventually said. We were overwhelmed with shock and sadness, clinging to each other for support – a moment we will never forget.

“It’s not fair!”

We repeated, again and again, devastated by the bad news. We grappled with feelings of parental guilt and the deep sadness for what awaited Raphael.

“There must be a way..”

we thought. And then, clarity dawned – we had a plan. We would find a cure for Raphael. After all, as his parents, we knew that ‘impossible’ was just a word, not our reality. And so, our quest began.

“We will find a cure…”

In just ten months following Raphael’s diagnosis, filled with love and endless parent determination, we launched Rafa’s Moonshot with the novel cause of finding a cure.

Global Developmental
Delays

Challenges in reaching milestones like sitting, walking, or talking.

Early-Onset
Epilepsy

Seizures, often starting in infancy, vary in type and severity.

Intellectual
Disability

Varying degrees of cognitive impairment.

Movement
Disorders

Challenges with motor skills, including issues with balance and coordination.

Speech
Impairment

Speech impairments or absence of speech.

Behavioral
Challenges

Including potential issues with attention, learning difficulties, and sometimes features of autism.

Our STXBP1 Research Today

Rafa’s Moonshot Research spearheads innovative treatments for STXBP1 and related disorders:

• Building disease models
• Developing advanced therapeutics
• Exploring cutting-edge technologies

Rare Diseases by the Numbers

7000+

Single-gene rare genetic diseases are known today

400m

People are diagnosed with rare genetic disorders.

95%

Of rare diseases do not have a single FDA-approved drug treatment.

Our Research Partners

Recent Articles

A Grant to Prof. Illana Gozes: Developing R292C STXBP1 Mouse Model

A Grant to Prof. Illana Gozes: Developing R292C STXBP1 Mouse Model

We are pleased to announce a continuation grant to Prof. Illana Gozes at Tel Aviv University to establish and comprehensively characterize a mouse model harboring the R292C point mutation in STXBP1. This variant is one of the pathogenic heterozygous mutations known to disrupt synaptic vesicle fusion processes and is clinically associated with early-onset epileptic encephalopathy, […]

Half a Million Dollars for STXBP1 Research

Half a Million Dollars for STXBP1 Research

This year marks a significant milestone in our mission to advance research into STXBP1-related disorders. With over $500,000 in combined funding, we’re powering groundbreaking organoid and rat chimera studies that will deepen our understanding of the disorder and accelerate the path toward effective treatments. A Strategic Grant to Advance Brain Research Earlier this year, Rafa’s […]

The Power of Early Diagnosis

The Power of Early Diagnosis

In this blog, I will explore the complexities of rare genetic diseases, emphasizing the crucial role of early diagnosis in improving treatment and quality of life. You’ll find personal anecdotes, expert insights, and practical advice on navigating the diagnostic process.  Part 1: Our Journey Giving birth to a child with a rare genetic disease brings […]